The public health impact of the Government's decision to downgrade cannabis is disclosed today in official figures showing a 50 per cent rise in the number of people requiring medical treatment after using the drug.
Since cannabis was downgraded from a Class B to a Class C drug, the number of adults being treated in hospitals and clinics in England for its effects has risen to more than 16,500 a year. In addition, the number of children needing medical attention after smoking the drug has risen to more than 9,200.Doctors say cannabis abuse can contribute to a series of mental health problems
Almost 500 adults and children are treated in hospitals and clinics
every week for the effects of cannabis.Its health toll is revealed in official data compiled by health authorities and obtained by The Daily Telegraph.
Drug campaigners last night said the figures proved Labour's decision to reclassify cannabis in January 2004, which made the penalties for its possession less severe, was badly mistaken and had sent out the wrong signals about it being a "soft" drug.
Doctors say cannabis abuse can contribute to mental health problems
including forms of psychosis, paranoia and schizophrenia. There can be
harmful physical side-effects, disrupting blood pressure and
exacerbating heart and circulation disorders. The data will add to the pressure on Gordon Brown to reverse its reclassification when a review of the decision by Home Office scientific advisers concludes in the Spring.
Elizabeth Burton-Phillips, a leading campaigner on drug issues since her son, Nick Mills, killed himself in despair at his addiction four years ago, said: "These results are shocking and dreadful. What more evidence do you need? You cannot sweep this under the carpet any longer. Children have to be told of the dangers of this what is wrongly called a young minds."
James Clappison, a Conservative member of the Commons home affairs
committee, said: "The reclassification of cannabis sent the wrong
message and was clearly the wrong decision. These figures show the
evident dangers of cannabis abuse and support the case for the drug
being restored to Category B."
The health authority figures show that 16,685 adults were treated by
English hospital trusts after abusing cannabis in 2006-07. The previous
year, it was 14,828 - up from 11,057 in 2004-05.
The data also shows that the number of children treated for using
cannabis has risen from 8,014 in 2005-06 to 9,259 last year. In total,
25,944 people were treated for cannabis use last year - around 498 a
week. In addition, around 70,000 people are treated for mental disorder
as outpatients each year.
The figures suggest health authorities are treating more people for
cannabis abuse than there are patients who have heart bypass operations
or treatment for colon cancer. Some 21,000 people a year have a bypass
operation and colon cancer is contracted by some 22,000 people a year.
Downgrading cannabis to a Class C drug placed it alongside steroids and
some prescription anti-depressants. Possession of them can lead to a
two-year prison sentence, but charges are rarely brought against people
found with small quantities of such drugs. Class B drugs however, include more dangerous substances such as amphetamines. People found in possession of Class B drugs can face a five-year jail term and an unlimited fine.
There is no "substitute medication" available to treat cannabis
problems, so the majority of National Health Service treatment is
carried out by psychiatrists, therapists and counsellors.
The independent review into its reclassification, by the Advisory
Council on the Misuse of Drugs, was prompted by growing concern about
the increasing prevalence of new high-strength forms of cannabis.
So-called "super-skunk" leaves can be twice as potent as more
traditional cannabis resin. Advocates of downgrading or legalising cannabis say the risks are low compared to those of alcohol and tobacco. Some sufferers of chronic conditions like multiple sclerosis say the drug provides vital pain relief.
Many doctors say the risks outweigh the benefits, and the British
Medical Association yesterday said the latest treatment figures
strengthened its opposition to the decision to downgrade the drug.
A BMA spokesman said: "This is drug that is mostly smoked, so that can
cause lung damage and cancer. There are also concerns about the
potential negative effect cannabis has on users' psychiatric state."
Addaction, a charity that treats people with drug problems, warned that
children suffered particularly from cannabis abuse. "Young people often
use cannabis at crucial development stages in their lives, and it does
have serious impacts on mental health and physical development," a
spokesman said.
Last night, the Department of Health insisted that the rising numbers of treatments reflect improvements in drug treatment and not rising
cannabis use.
However, the department also announced yesterday that the budget for the National Treatment Agency, which co-ordinates drug treatment, will be frozen at 2007 levels for the next three years. The agency will also be expected to find "efficiency savings" of £50 million a year from its
£398 million annual budget. Despite the freeze in his budget, Paul Hayes, the head of the agency, insisted that the number of drug treatments it can fund will rise.
"By becoming more efficient at delivering the best outcomes for
individuals we will be able to continue to increase the number of people into treatment, while increasing treatment effectiveness," he said.
Andrew Lansley, the Conservative health spokesman, said Labour was
wasting vast amounts of money. "The Government is ignoring the fact that its drug treatment policy is fundamentally misguided. Conservatives have promised to introduce abstinence-based treatment for drug addicts to help them get off drugs for good," he said.
Source: http://www.telegraph.co.uk/news/main.jhtml?xml=/news/2008/01/11/ncnbis111.
Showing posts with label schizophrenia. Show all posts
Showing posts with label schizophrenia. Show all posts
Cannabis link to 80 per cent of new mental cases
By MATTHEW HICKLEY
Eighty per cent of patients newly-diagnosed with schizophrenia and other psychiatric illnesses are heavy users of cannabis, scientists have warned ministers.
The shocking figure emerged in a dossier submitted to Whitehall drug advisers as Gordon Brown weighs up whether or not to reverse Labour's "softly-softly" policy of downgrading cannabis. Campaigners have pointed to a flood of scientific evidence on the devastating damage the drug can do to mental and physical health.
Much of it has come in the four years since David Blunkett decided to reclassify cannabis from Class B to Class C, so that most users caught by police no longer face arrest or a criminal record. The Prime Minister ordered a review of that policy last summer following years of warnings that stronger "skunk" varieties of cannabis are wreaking havoc on users' mental health.
The Government's Advisory Council on the Misuse of Drugs will take evidence from leading academics next week before sending its latest official advice to ministers. Psychiatrist Professor Peter Jones, of Cambridge University, says in the dossier that eight out of ten newly-diagnosed psychiatric disorders affect heavy or dependent cannabis users.
He warns that children who are starting to smoke cannabis as young as ten or 11 could be trebling their risk of schizophrenia. Other new evidence of harm to mental health includes a UK study suggesting that by 2010 as many as 25 per cent of all cases of schizophrenia would be actually triggered by cannabis use. In a letter published in the Times yesterday, leading researchers and policy experts urged ministers to read the evidence and to toughen the law again.
A U.S. study found that smoking just half a cannabis joint could trigger schizophrenia-related symptoms.
Biologist Mary Brett of the Europe Against Drugs campaign, a signatory to the letter, said: "Every single piece of research around the world now emerging is bad news." A Home Office spokesman said: "We have always said that cannabis is an illegal and harmful drug. But to tackle drugs in the most effective way we need to monitor and review the ways in which we reduce the harm caused by illegal substances. That is why we are reviewing cannabis classification."
Source:http://www.dailymail.co.uk/pages/live/articles/health Jan 2008
Subscribe to:
Posts (Atom)